Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States. [PDF]
Value Health, 2021 Basu A, Gandhay VJ.
europepmc +1 more source
Equity weights for economic evaluation: An Australian Discrete Choice Experiment, CHERE Working Paper 2008/5 [PDF]
Background: Economic evaluation of healthcare interventions and technologies using the quality-adjusted life year (or life year) usually values outcomes independently of who they accrue to.
Gisselle Gallego, Richard Norman
core
Epilepsy‐Associated Variants of a Single SCN1A Codon Exhibit Divergent Functional Properties
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Pathogenic variants in SCN1A, which encodes the voltage‐gated sodium channel NaV1.1, are associated with multiple epilepsy syndromes exhibiting a range of clinical severity. SCN1A variants are reported in different syndromes, including Dravet syndrome, which is associated with loss‐of‐function, whereas neonatal/infantile‐onset ...
Lanie N. Liebovitz +3 more
wiley +1 more source
BMC NephrologyBackground There is little economic evidence on different modalities among patients with end-stage renal disease (ESRD) in Iran. This study aimed to assess the cost-utility of peritoneal dialysis (PD) and hemodialysis (HD) among ESRD patients in Iran ...
Mahmood Yousefi +4 more
doaj +1 more source
Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study. [PDF]
Clin Psychol Eur, 2021 Ulbrich L, Kröger C.
europepmc +1 more source
A Systematic Review and Meta‐Analysis of the Recurrence of Autoimmune Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Autoimmune encephalitis (AE) is a disease with a potential for recurrence, and patients receive immunotherapy to prevent it. However, there is no consensus on the duration of immunotherapy. This study aimed to determine the recurrence rate and identify the risk factors for AE to provide guidance on the duration of immunotherapy ...
Shangkai Bai +5 more
wiley +1 more source
The value of health-Empirical issues when estimating the monetary value of a quality-adjusted life year based on well-being data. [PDF]
Health Econ, 2021 Himmler S +3 more
europepmc +1 more source
Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini +28 more
wiley +1 more source
Measuring quality of life for an economic evaluation of aphasia: First steps [PDF]
, 2013 Health economists typically use the Quality Adjusted Life Year (QALY) when conducting economic evaluations of healthcare investments. We have begun investigating methods to obtain QALYs for aphasia by developing a pictographic version of the Time Trade ...
Hoch, Jeffery +7 more
core
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem +17 more
wiley +1 more source